Related Experiment Videos
Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes
Scott D Kobayashi1, Jovanka M Voyich, Kevin R Braughton
1Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Abstract:
Polymorphonuclear leukocytes (PMNs) are essential to innate immunity in humans and contribute significantly to inflammation. Although progress has been made, the molecular basis for termination of inflammation in humans is incompletely characterized. We used human oligonucleotide microarrays to identify genes encoding inflammatory mediators that were differentially regulated during the induction of apoptosis. One hundred thirty-three of 212 differentially expressed genes encoding proinflammatory factors, signal transduction mediators, adhesion molecules, and other proteins that facilitate the inflammatory response were down-regulated during the induction of apoptosis following PMN phagocytosis. Among these, 42 genes encoded proteins critical to the inflammatory response, including receptors for IL-8 beta, IL-10 alpha, IL-13 alpha 1, IL-15 alpha, IL-17, IL-18, C1q, low-density lipoprotein, IgG Fc (CD32), and formyl peptide, Toll-like receptor 6, platelet/endothelial cell adhesion molecule-1 (CD31), P-selectin (CD62), IL-1 alpha, IL-16, and granulocyte chemoattractant protein-2 were down-regulated. Many of these genes were similarly down-regulated during Fas-mediated or camptothecin-induced apoptosis. We used flow cytometry to confirm that IL-8R beta (CXCR2) and IL-1 alpha were significantly down-regulated during PMN apoptosis. We also discovered that 23 genes encoding phosphoinositide and calcium-mediated signal transduction components, which comprise complex pathways essential to the inflammatory response of host cells, were differentially regulated during PMN apoptosis. Importantly, our data demonstrate that PMNs down-regulate proinflammatory capacity at the level of gene expression during induction of apoptosis. These findings provide new insight into the molecular events that resolve inflammation following PMN activation in humans.
Insights
Polymorphonuclear leukocytes (PMNs) reduce inflammation by down-regulating key genes during apoptosis. This study reveals molecular mechanisms for inflammation resolution in humans.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Polymorphonuclear leukocytes (PMNs) are crucial for innate immunity and inflammation.
- The molecular mechanisms terminating inflammation in humans are not fully understood.
Purpose of the Study:
- To identify genes regulated during apoptosis-induced inflammation resolution.
- To elucidate the molecular basis for the termination of inflammation by PMNs.
Main Methods:
- Human oligonucleotide microarrays were used to analyze gene expression during PMN apoptosis.
- Flow cytometry was employed to validate gene expression changes.
Main Results:
- 133 of 212 differentially expressed genes involved in inflammation were down-regulated during PMN apoptosis.
- Key inflammatory mediators, receptors, and signal transduction components showed reduced expression.
- Down-regulation of IL-8R beta (CXCR2) and IL-1 alpha was confirmed via flow cytometry.
Conclusions:
- PMNs actively decrease their proinflammatory capacity at the gene expression level during apoptosis.
- This study provides novel insights into the molecular events resolving inflammation post-PMN activation.